A California jury on Friday awarded $40m to two women who said Johnson & Johnson’s baby powder was to blame for their ovarian cancer.
The jury in Los Angeles superior court awarded $18m to Monica Kent and $22m to Deborah Schultz and her husband after finding that Johnson & Johnson knew for years its talc-based products were dangerous but failed to warn consumers.
Erik Haas, Johnson & Johnson’s worldwide vice-president of litigation, said in a statement the company plans to “immediately appeal this verdict and expect to prevail as we typically do with aberrant adverse verdicts”.
A spokesperson for the plaintiffs did not immediately respond to a request for comment.
Kent was diagnosed with ovarian cancer in 2014, according to court records. Schultz was diagnosed in 2018. Both women are California residents who say they used J&J’s baby powder after bathing for 40 years. Their treatments for ovarian cancer have involved major surgeries and dozens of rounds of chemotherapy, they testified at the trial.
In closing arguments that Reuters viewed on Courtroom View Network, Andy Birchfield, an attorney for the women, told the jury that Johnson & Johnson knew as far back as the 1960s that its product could cause cancer.
New guidelines for managing cholesterol call for more aggressive prevention and earlier treatment, including a recommendation...
More than 100 substances widely used in common US foods, supplements and beverages underwent no health...
